Bleichmar Fonti & Auld has filed a securities class action lawsuit against Ardent Health Inc. and certain senior executives, alleging the company misrepresented how it assessed the collectability of accounts receivable and delayed recognizing losses on uncollectable accounts. The suit, brought under the Securities Exchange Act of 1934, follows a more than 33% share-price drop after Ardent disclosed a $43 million revenue reduction tied to revised collection trend evaluations and a $54 million increase in professional liability reserves. Investors have until March 9, 2026 to seek appointment as lead plaintiff in the case pending in federal court in Tennessee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602230706PRIMZONEFULLFEED9658648) on February 23, 2026, and is solely responsible for the information contained therein.